SCHEMBL7998468

SCHEMBL7998468

Cc1nc(CCCC/C=C/c2cccc(-c3nn(C)nc3-c3ccccc3)c2)cs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.37
HDAC1 Q13547 8/20 0.34
HDAC8 Q9BY41 8/20 0.34
HDAC6 Q9UBN7 8/20 0.34
MAPT P10636 2/20 0.34
SLC6A3 Q01959 2/20 0.34
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998514 0.97 PKM (0.38) PKMHDAC1HDAC8HDAC6MAPT
SCHEMBL7998465 0.93 PKM (0.39) PKMHDAC1HDAC8HDAC6MAPT
SCHEMBL7998466 0.87 PKM (0.36) PKMHDAC1HDAC8HDAC6MAPT
SCHEMBL7998518 0.82 PKM (0.33) PKMHDAC1HDAC8HDAC6SLC6A3
SCHEMBL8007754 0.82 PKM (0.42) PKMMAPTSLC6A3SMN1; SMN2GAA
SCHEMBL8010413 0.81 PKM (0.41) PKMMAPTSLC6A3SMN1; SMN2GAA
SCHEMBL7998569 0.81 PKM (0.41) PKMMAPTSLC6A3SMN1; SMN2GAA
SCHEMBL8008226 0.81 PKM (0.32) PKMMAPTSLC6A3SMN1; SMN2ALDH1A1
SCHEMBL8008282 0.80 PKM (0.42) PKMMAPTSLC6A3SMN1; SMN2GAA
SCHEMBL10260051 0.79 SLC6A3 (0.34) HDAC1HDAC8HDAC6SLC6A3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009134987-A1 DIFLUOROMETHYL-CONTAINING MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-11-05 WO disclosed